Miyazaki, Dai
Fukagawa, Kazumi
Fukushima, Atsuki
Fujishima, Hiroshi http://orcid.org/0000-0002-5926-5826
Uchio, Eiichi
Ebihara, Nobuyuki
Shoji, Jun
Takamura, Etsuko
Namba, Kenichi
Ohashi, Yuichi
Okamoto, Shigeki
Satake, Yoshiyuki
Ohtsu, Hiroshi http://orcid.org/0000-0003-3261-8828
Shimizu, Yumiko
Inoue, Yoshitsugu
Funding for this research was provided by:
Santen Pharmaceutical
Article History
Received: 12 July 2019
Accepted: 18 November 2019
First Online: 3 December 2019
Competing interests
: Dai Miyazaki reports lecture fees from Santen Pharmaceutical, Senju Pharmaceutical, and Alcon outside the submitted work. Kazumi Fukagawa reports lecture fee from Santen Pharmaceutical outside the submitted work. Atsuki Fukushima reports grants from Santen Pharmaceutical, Senju Pharmaceutical, Alcon Pharma (Novartis), Tanabe-Mitsubishi, Pfizer, and Ohtsuka, personal fees from Santen Pharmaceutical, Senju Pharmaceutical, Alcon Pharma (Novartis), Tanabe-Mitsubishi, Pfizer, Ohtsuka, Eisai, Abbvie, Ohtsuka, Kowa, Kyowa-Kirin, and Rohto, other from Santen Pharmaceutical outside the submitted work. Jun Shoji reports personal fees from Santen Pharmaceutical, Senju Pharmaceutical, and Alcon Pharma outside the submitted work. Kenichi Namba reports grants from Abbvie, Mitsubishi Tanabe, and Eisai, lecture fees from HOYA, Alcon, Pfizer, Novartis, Kowa, Senju Pharmaceutical, Mitsubishi Tanabe, Eisai, Abbvie, and Santen Pharmaceutical outside the submitted work. Hiroshi Ohtsu reports personal fees from Deloitte Tohmatsu Consulting LLC, personal fees and non-financial support from Public Health Research Foundation, outside the submitted work. Yoshitsugu Inoue reports grants and consultant fee from Senju Pharmaceutical, grants from Santen Pharmaceutical and Alcon outside the submitted work. Hiroshi Fujishima, Eiichi Uchio, Nobuyuki Ebihara, Etsuko Takamura, Yuichi Ohashi, Shigeki Okamoto, Yoshiyuki Satake, and Yumiko Shimizu have nothing to disclose.